Citations

Clear

16280 citation(s) found for "Yu, David".

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
Rajkumar, S. Vincent , Harousseau, Jean‐Luc, Durie, Brian G.M. , Dimopoulos, Meletios Α. , Kyle, Robert A. , Bladé, Joan , Richardson, Paul G. , Orlowski, Robert Z. , Avet‐Loiseau, Hervé , Palumbo, Antonio , Zonder, Jeffrey A. , Vesole, David H., Sezer, Orhan , Munshi, Nikhil C. , Miguel, Jesús F. San , 1, on behalf of the International Myeloma Workshop Consensus Panel, Cavo, Michèle , García‐Sánz, Ramón , Anderson, Kenneth C. , Richardson, Paul Gerard Guy , Orlowski, Robert Z. , Siegel, David S. , Jagannath, Sundar , Facon, Thierry T.F. , Lonial, Sagar , Ludwig, Heinz , 1, on behalf of the International Myeloma Workshop Consensus Panel, Rajkumar, S Vincent , Dimopoulos, Meletios A , San-Miguel, Jesus , Garcia-Sanz, Ramon

Mayo Clinic

Blood | February 4, 2011 | Volume: 117 | Issue: 18 | Pages: 4691-4695

10.1182/blood-2010-10-299487 | PMID 21292775 Get It

Abstract It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.
Setting the Bar for Laparoscopic Resection of Sporadic Insulinoma
Richards, Melanie L. , Thompson, Geoffrey B. , Farley, David R. , Kendrick, Michael L. , Service, John F., Grant, Clive S., Vella, Adrian

Mayo Clinic

World Journal of Surgery | February 3, 2011 | Volume: 35 | Issue: 4 | Pages: 785-789

10.1007/s00268-011-0970-5 | PMID 21293961 Get It

AbstractBackgroundLaparoscopic insulinoma resection (LIR) for sporadic disease is increasingly supported as a feasible and safe operation in small series of patients. To determine whether LIR is an acceptable alternative to the open operation, it is necessary to compare LIR to historical controls. The purpose of this study was to identify the skills and technology needed for LIR and establish outcome standards.MethodsA database of patients with benign sporadic insulinoma who underwent an open procedure at the Mayo Clinic was reviewed for demographics, imaging, operative/pathology reports, and outcomes. Outcomes were compared to a world‐wide meta‐analysis of patients who had undergone LIR reported in the English literature between 1996 and 2009.ResultsTwo hundred fifteen patients underwent a primary open operation for benign sporadic insulinoma. Solitary tumors were found in 97%. Meta‐analysis identified 232 patients who underwent LIR. The open and LIR groups underwent comparable operations that included enucleations (64 vs. 68%) and distal pancreatectomies (28 vs. 35%) (p = 0.06). The mean estimated blood loss, operating time, and length of stay were comparable between the open and LIR groups (p = NS). Pancreatic fistula occurred more often in the LIR group (24 vs. 11%, p < 0.05). A curative operation was performed in 98% of control patients and in 99% of the LIR group (p = NS).ConclusionsMultiple insulinomas are rare and a focused resection guided by imaging may be performed. LIR is associated with an increased incidence of pancreatic fistula. Success of LIR will depend on accurate multimodality preoperative imaging, skilled use of lap‐US to replace palpation for localization, and safe methods to dissect the tumor adjacent to the pancreatic duct.
Revision of the criteria for Alzheimer's disease: A symposium
DeKosky, Steven T. , Phelps, Creighton H., Petersen, Ronald C. , Frank, Richard , Schenk, Dale, Masterman, Donna, Siemers, Eric , Cedarbaum, Jesse M. , Morimoto, Bruce H., Khachaturian, Ara S. , Mohs, Richard C. , Carrillo, María C. , Knopman, David S. , Gold, Michael , Miller, David S.

Mayo Clinic

Alzheimer's & Dementia | February 2, 2011 | Volume: 7 | Issue: 1 | Pages: No page available

10.1016/j.jalz.2010.12.007 | PMID 21322828 Get It

The current criteria for classification of Alzheimer's disease (AD) have deficiencies that limit drug development, research, and practice. The current standard for the clinical diagnosis of AD, the National Institute of Neurological and Communicative Disorders and Stroke (now known as the National Institute of Neurological Disorders and Stroke), and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association) criteria, are nearly 25 years old and have not been revised to incorporate advances in the epidemiology and genetics of AD, studies of clinicopathologic correlations and recent studies of potential diagnostic biomarkers. In a very real sense our ability to diagnose AD with a very high level of certainty has outpaced our current diagnostic criteria. The Alzheimer's Association Research Roundtable convened a meeting in April 2009 to discuss new data and technologies that could, with further development, enable improvements in the clinical diagnosis of AD, especially in its earliest and mildest stages. This meeting reviewed the current standards for detecting and defining the clinical presentation of AD and discussed areas that could contribute to earlier and more accurate definitive clinical diagnosis. These included clinical, neuropsychological, and other performance‐based assessments, genetic contributions, and biochemical and neuroimaging biomarkers that could reflect AD pathology and lead to better ascertainment of AD, mild cognitive impairment, and presymptomatic AD.
Use of the Habib 4 × Radiofrequency-Assisted Bipolar Hemostatic Device to Avoid Warm Ischemia in Select Large Partial Nephrectomies: Description and Video of Technique
Rogers, Alexandra , Thiel, David D. , Brisson, Theodore E., Igel, Todd C.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | February 1, 2011 | Volume: 21 | Issue: 2 | Pages: 153-156

10.1089/lap.2010.0347 | PMID 21284516 Get It

Resection of hepatocellular carcinoma in patients without cirrhosis
Smoot, Rory L. , Nagorney, David M. , Chandan, Vishal S. , Que, Florencia G., Schleck, Cathy D. , Harmsen, William S. , Kendrick, Michael L. , Smoot, Rory L

Mayo Clinic

British Journal of Surgery | January 31, 2011 | Volume: 98 | Issue: 5 | Pages: 697-703

10.1002/bjs.7401 | PMID 21280030 Get It

Abstract Background Outcomes for patients with hepatocellular carcinoma (HCC) without cirrhosis and factors associated with disease progression remain unclear. The goals of this single-institution study were to define the outcomes for such patients, and to determine factors associated with survival and disease progression. Methods This was a retrospective review of consecutive patients with HCC without cirrhosis who underwent hepatic resection between 1985 and 2003. Survival was estimated by the Kaplan–Meier method and risk factors were identified by Cox proportional hazards models. Results A total of 143 patients were enrolled, of whom 29·4 per cent had identifiable risk factors for chronic liver disease. Major resection (at least three segments) was undertaken in 63·6 per cent of patients. The operative mortality rate was 3·5 per cent. Median disease-free survival was 2·4 years. Multivariable analysis revealed presence of multiple tumours as the only independent predictor of tumour recurrence. Median overall survival was 3·3 years. Factors independently associated with decreased overall survival were multiple tumours, high histological grade, perioperative transfusion, male sex and age at least 66 years. Conclusion Patients with HCC but without cirrhosis have acceptable outcomes after resection. Specific risk factors for the development of HCC in these patients have yet to be defined.
Myasthenic syndrome caused by plectinopathy
Selcen, Duygu , Juel, Vern C. , Hobson‐Webb, Lisa D., Smith, Edward C. , Stickler, David E., Bite, Anna V., Ohno, Kinji , Engel, Andrew G.

Mayo Clinic

Neurology | January 24, 2011 | Volume: 76 | Issue: 4 | Pages: 327-336

10.1212/wnl.0b013e31820882bd | PMID 21263134 Get It

Bro1 binding to Snf7 regulates ESCRT-III membrane scission activity in yeast
Wemmer, Megan, Azmi, Ishara F. , Davies, Brian A., Katzmann, David J. , Odorizzi, Greg , West, Matthew

Mayo Clinic

Journal of Cell Biology | January 24, 2011 | Volume: 192 | Issue: 2 | Pages: 295-306

10.1083/jcb.201007018 | PMID 21263029 Get It

Endosomal sorting complexes required for transport (ESCRTs) promote the invagination of vesicles into the lumen of endosomes, the budding of enveloped viruses, and the separation of cells during cytokinesis. These processes share a topologically similar membrane scission event facilitated by ESCRT-III assembly at the cytosolic surface of the membrane. The Snf7 subunit of ESCRT-III in yeast binds directly to an auxiliary protein, Bro1. Like ESCRT-III, Bro1 is required for the formation of intralumenal vesicles at endosomes, but its role in membrane scission is unknown. We show that overexpression of Bro1 or its N-terminal Bro1 domain that binds Snf7 enhances the stability of ESCRT-III by inhibiting Vps4-mediated disassembly in vivo and in vitro. This stabilization effect correlates with a reduced frequency in the detachment of intralumenal vesicles as observed by electron tomography, implicating Bro1 as a regulator of ESCRT-III disassembly and membrane scission activity.
Vascular and Interventional Imaging: Case Review Series, 2nd ed.
Sella, David M.

Mayo Clinic

American Journal of Roentgenology | January 21, 2011 | Volume: 196 | Issue: 2 | Pages: W222-W222

10.2214/ajr.10.5219 Get It

Ultrasound-Guided Procedures
Sella, David M.

Mayo Clinic

American Journal of Roentgenology | January 21, 2011 | Volume: 196 | Issue: 2 | Pages: W221-W221

10.2214/ajr.10.5218 Get It

Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 2
Seshadri, Sudha , Beiser, Alexa , Au, Rhoda , Wolf, Philip A. , Evans, Denis A., Petersen, Ronald C. , Rocca, Walter A. , Kawas, Claudia H. , Corrada, María M. , Plassman, Brenda L. , Langa, Kenneth M. , Chui, Helena C., Wilson, Robert S. , Wilson, R. J. , Knopman, David S. , Seshadri, Sudha , Au, Rhoda

Mayo Clinic

Alzheimer's & Dementia | January 20, 2011 | Volume: 7 | Issue: 1 | Pages: 35-52

10.1016/j.jalz.2010.12.002 | PMID 21255742 Get It

This article focuses on the effects of operational differences in case ascertainment on estimates of prevalence and incidence of cognitive impairment and/or dementia of the Alzheimer type. Experience and insights are discussed by investigators from the Framingham Heart Study, the East Boston Senior Health Project, the Chicago Health and Aging Project, the Mayo Clinic Study of Aging, the Baltimore Longitudinal Study of Aging, and the Aging, Demographics, and Memory Study. There is a general consensus that the single most important factor determining prevalence estimates of Alzheimer's disease (AD) is the severity of cognitive impairment used as a threshold to define cases. Studies that require a level of cognitive impairment in which persons are unable to provide self‐care will have much lower estimates than the studies aimed at identifying persons in the earliest stages of AD. There are limited autopsy data from the aforementioned epidemiological studies to address accuracy in the diagnosis of etiological subtype, namely the specification of AD alone or in combination with other types of pathology. However, other community‐based cohort studies show that many persons with mild cognitive impairment and also some persons without dementia or mild cognitive impairment meet pathological criteria for AD, thereby suggesting that the number of persons who would benefit from an effective secondary prevention intervention is probably higher than the published prevalence estimates. Improved accuracy in the clinical diagnosis of AD is anticipated with the addition of molecular and structural biomarkers in the next generation of epidemiological studies.